{"id":"https://openalex.org/W1982944256","doi":"https://doi.org/10.1038/sj.gt.3300369","title":"High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS","display_name":"High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS","alternate_titles":[],"publication_year":1997,"publication_date":"1997-02-01","ids":{"openalex":"https://openalex.org/W1982944256","doi":"https://doi.org/10.1038/sj.gt.3300369","mag":"1982944256","pmid":"https://pubmed.ncbi.nlm.nih.gov/9081703"},"language":"en","primary_location":{"id":"doi:10.1038/sj.gt.3300369","doi":"https://doi.org/10.1038/sj.gt.3300369","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.gt.3300369","pdf_url":null,"source":{"id":"https://openalex.org/S65405509","display_name":"Gene Therapy","issn_l":"0969-7128","issn":["0969-7128","1476-5462"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gene Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1982944256"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070359142","display_name":"Ivan Plavec","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I Plavec","raw_affiliation_strings":["Progenesys Program, SyStemix Inc, Palo Alto, CA 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, CA 94304, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"M Agarwal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Agarwal","raw_affiliation_strings":["Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","Progenesys Program, SyStemix Inc, Palo Alto, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","institution_ids":[]},{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108623859","display_name":"KE Ho","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"KE Ho","raw_affiliation_strings":["Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","Genentech, Inc, South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","institution_ids":[]},{"raw_affiliation_string":"Genentech, Inc, South San Francisco, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M Pineda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Pineda","raw_affiliation_strings":["Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","Progenesys Program, SyStemix Inc, Palo Alto, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","institution_ids":[]},{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000502918","display_name":"Jennifer Auten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Auten","raw_affiliation_strings":["Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","Progenesys Program, SyStemix Inc, Palo Alto, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","institution_ids":[]},{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110202613","display_name":"J Baker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Baker","raw_affiliation_strings":["Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","Progenesys Program, SyStemix Inc, Palo Alto, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","institution_ids":[]},{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"H Matsuzaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155803","display_name":"Affymetrix (United States)","ror":"https://ror.org/012kjw534","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142480","https://openalex.org/I4387155803"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H Matsuzaki","raw_affiliation_strings":["Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","Affymetrix, Santa Clara, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","institution_ids":[]},{"raw_affiliation_string":"Affymetrix, Santa Clara, USA","institution_ids":["https://openalex.org/I4387155803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109294371","display_name":"Sonia Escaich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Escaich","raw_affiliation_strings":["Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","Rh\u00f4ne Poulenc Rorer, Vitry-sur-Seine, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","institution_ids":[]},{"raw_affiliation_string":"Rh\u00f4ne Poulenc Rorer, Vitry-sur-Seine, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109936370","display_name":"Mark L. Bonyhadi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Bonyhadi","raw_affiliation_strings":["Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","Progenesys Program, SyStemix Inc, Palo Alto, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","institution_ids":[]},{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024850912","display_name":"Ernst B\u00f6hnlein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E B\u00f6hnlein","raw_affiliation_strings":["Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","Progenesys Program, SyStemix Inc, Palo Alto, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, 3155 Porter Drive, CA 94304, USA","institution_ids":[]},{"raw_affiliation_string":"Progenesys Program, SyStemix Inc, Palo Alto, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3790,"currency":"USD","value_usd":3790},"apc_paid":null,"fwci":5.6008,"has_fulltext":false,"cited_by_count":75,"citation_normalized_percentile":{"value":0.96708089,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"4","issue":"2","first_page":"128","last_page":"139"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.2061000019311905,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-replication-inhibition","display_name":"HIV-1 replication inhibition","score":0.890999972820282},{"id":"https://openalex.org/keywords/retroviral-vectors","display_name":"retroviral vectors","score":0.7609999775886536},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8790000081062317},{"id":"https://openalex.org/keywords/moloney-murine-leukemia-virus","display_name":"Moloney murine leukemia virus","score":0.8700000047683716},{"id":"https://openalex.org/keywords/antiviral-gene-expression","display_name":"antiviral gene expression","score":0.6690000295639038},{"id":"https://openalex.org/keywords/primary-t-cells","display_name":"primary T cells","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.8638207316398621},{"id":"https://openalex.org/C199491388","wikidata":"https://www.wikidata.org/wiki/Q1869477","display_name":"Long terminal repeat","level":4,"score":0.7573018074035645},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.6908378005027771},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.5849325656890869},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5749682188034058},{"id":"https://openalex.org/C32470452","wikidata":"https://www.wikidata.org/wiki/Q2298489","display_name":"Viral vector","level":4,"score":0.5190425515174866},{"id":"https://openalex.org/C2779562191","wikidata":"https://www.wikidata.org/wiki/Q673848","display_name":"Murine leukemia virus","level":3,"score":0.5081958770751953},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.49073588848114014},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4901960492134094},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.47993379831314087},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.4649786949157715},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.430332750082016},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.4247852563858032},{"id":"https://openalex.org/C145103041","wikidata":"https://www.wikidata.org/wiki/Q1151519","display_name":"Embryonic stem cell","level":3,"score":0.4199673533439636},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35995960235595703},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2036798596382141},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.0992894172668457},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012190","descriptor_name":"Retroviridae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015496","descriptor_name":"CD4-Positive T-Lymphocytes","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D015694","descriptor_name":"Gene Products, rev","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015694","descriptor_name":"Gene Products, rev","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054321","descriptor_name":"rev Gene Products, Human Immunodeficiency Virus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/sj.gt.3300369","doi":"https://doi.org/10.1038/sj.gt.3300369","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.gt.3300369","pdf_url":null,"source":{"id":"https://openalex.org/S65405509","display_name":"Gene Therapy","issn_l":"0969-7128","issn":["0969-7128","1476-5462"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gene Therapy","raw_type":"journal-article"},{"id":"pmid:9081703","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9081703","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gene therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2068904131","https://openalex.org/W2127810364","https://openalex.org/W1999441561","https://openalex.org/W2072466707","https://openalex.org/W2105086165","https://openalex.org/W2084903745","https://openalex.org/W2465565273","https://openalex.org/W2105824105","https://openalex.org/W1992463443"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1982944256","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
